Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Orvosi Hetilap
|
May 8, 2013
[Intravenous immunoglobulin treatment in idiopathic inflammatory myopathy]
Levente Bodoki, Melinda Vincze, Zoltán Griger, et al.
Orvosi Hetilap
|
October 6, 2014
[Epidemiology of idiopathic inflammatory myopathy in Hungary]
Melinda Nagy-Vincze, Levente Bodoki, Zoltán Griger, et al.
Orvosi Hetilap
|
June 24, 2014
[Anti-NXP2-positive dermatomyositis associated with ulcerative colitis and celiac disease]
Levente Bodoki, Melinda Nagy-Vincze, Zoltán Griger, et al.
Ideggyogyaszati Szemle
|
April 7, 2015
[Inclusion body myositis]
Levente Bodoki, Melinda Vincze, Zoltán Griger, et al.
Ideggyogyaszati Szemle
|
December 19, 2014
[Anti-signal recognition particle autoantibody positive myopathy]
Levente Bodoki, Melinda Vincze, Tibor Hortobágyi, et al.
Orvosi Hetilap
|
September 1, 2015
[Comparison of clinical characteristics and laboratory parameters of patients with dermatomyositis-specific autoantibodies and autoantibody-negative patients]
Levente Bodoki, Dóra Budai, Melinda Nagy-Vincze, et al.
Cureus
|
June 22, 2026
Checkpoint Inhibitor-Induced Raynaud's Phenomenon, Hypothyroidism, and Pneumonitis in Head and Neck Cancer: A Case Report
Levente Bodoki, Tamas Csonka, Zoltan Szekanecz, et al.
Autoimmunity Reviews
|
September 4, 2014
Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort
Levente Bodoki, Melinda Nagy-Vincze, Zoltán Griger, et al.
Orvosi Hetilap
|
September 2, 2014
[Risk factors for cancer in patients with myositis. Clinical, immunological characteristics and the role of the anti-p155/140 antibody]
Zsuzsanna Szankai, Melinda Nagy-Vincze, Levente Bodoki, et al.
Orvosi Hetilap
|
April 5, 2016
[The shades of anti-Jo1 positive antisynthetase syndrome in a Hungarian cohort]
Katalin Szabó, Melinda Nagy-Vincze, Levente Bodoki, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Orvosi Hetilap
|
May 8, 2013
[Intravenous immunoglobulin treatment in idiopathic inflammatory myopathy]
Levente Bodoki, Melinda Vincze, Zoltán Griger, et al.
Orvosi Hetilap
|
October 6, 2014
[Epidemiology of idiopathic inflammatory myopathy in Hungary]
Melinda Nagy-Vincze, Levente Bodoki, Zoltán Griger, et al.
Orvosi Hetilap
|
June 24, 2014
[Anti-NXP2-positive dermatomyositis associated with ulcerative colitis and celiac disease]
Levente Bodoki, Melinda Nagy-Vincze, Zoltán Griger, et al.
Ideggyogyaszati Szemle
|
April 7, 2015
[Inclusion body myositis]
Levente Bodoki, Melinda Vincze, Zoltán Griger, et al.
Ideggyogyaszati Szemle
|
December 19, 2014
[Anti-signal recognition particle autoantibody positive myopathy]
Levente Bodoki, Melinda Vincze, Tibor Hortobágyi, et al.
Orvosi Hetilap
|
September 1, 2015
[Comparison of clinical characteristics and laboratory parameters of patients with dermatomyositis-specific autoantibodies and autoantibody-negative patients]
Levente Bodoki, Dóra Budai, Melinda Nagy-Vincze, et al.
Cureus
|
June 22, 2026
Checkpoint Inhibitor-Induced Raynaud's Phenomenon, Hypothyroidism, and Pneumonitis in Head and Neck Cancer: A Case Report
Levente Bodoki, Tamas Csonka, Zoltan Szekanecz, et al.
Autoimmunity Reviews
|
September 4, 2014
Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort
Levente Bodoki, Melinda Nagy-Vincze, Zoltán Griger, et al.
Orvosi Hetilap
|
September 2, 2014
[Risk factors for cancer in patients with myositis. Clinical, immunological characteristics and the role of the anti-p155/140 antibody]
Zsuzsanna Szankai, Melinda Nagy-Vincze, Levente Bodoki, et al.
Orvosi Hetilap
|
April 5, 2016
[The shades of anti-Jo1 positive antisynthetase syndrome in a Hungarian cohort]
Katalin Szabó, Melinda Nagy-Vincze, Levente Bodoki, et al.
Page
of 4